Page 3 - Les meilleurs doctors traitant la maladie suivante : Cancer du cerveau - TOP -96 des médecins

Directeur du service de radiothérapie pour les tumeurs du système nerveux au centre médical de Tel Aviv – spécialisé en radiochirurgie et radiothérapie pour les tumeurs cérébrales.

• Plus de 14 ans d'expérience en oncologie, avec une spécialisation dans les tumeurs du cerveau et des nerfs
• Formé aux techniques avancées de radiothérapie au Duke University Medical Center
• Membre de l'Association internationale des neuro-oncologues
• Spécialisé dans le traitement des métastases cérébrales et des tumeurs cérébrales primitives

Le professeur associé Tahsin Ozatli est spécialisé dans le traitement des cancers du sein, du poumon et gastro-intestinaux à l'hôpital universitaire Istinye Liv.

• Expérimenté en oncologie médicale dans plusieurs hôpitaux turcs
• Ayant travaillé auparavant à la clinique d'oncologie d'Ankara
• Promu professeur associé en 2016

Le professeur Gül Alco est une experte en radio-oncologie à l'Université Medipol d'Istanbul, avec plus de 20 ans d'expérience.

• Se spécialiser en radio-oncologie pour le cancer du cerveau
• Professeur aux universités Demiroglu Bilim et Medipol
• Diplômée de la faculté de médecine de l'Université d'Istanbul

Le professeur associé Nail Paksoy apporte une vaste expertise en oncologie provenant de l'Institut d'oncologie de l'Université d'Istanbul et de l'hôpital Medipol Bahçelievler.

• Certifié par l'ESMO en oncologie médicale
• Participation à plus de 8 essais cliniques internationaux pour les cancers avancés
• Publication de plus de 30 articles de recherche sur les traitements innovants contre le cancer
• Spécialisation dans les thérapies ciblées et les approches d'oncologie de précision

Dr. Irfan Cicin is a Professor of Medical Oncology at the Trakya University Faculty of Medicine (2015–present). He has over 20 years of medical oncology experience and has held academic roles since 2010.

Education: MD, Istanbul University – Cerrahpaşa (1991–1997). Residency in Internal Medicine, Trakya University (1997–2002). Fellowship in Medical Oncology, Trakya University (2002–2004).

Practice: Medical Oncologist, Trakya University (2005–2008). Medical Oncologist, Elazığ Training and Research Hospital (2008–2010). Associate Professor of Medical Oncology, Trakya University (2010–2015). He previously served as a physician in the Turkish Air Force at Etimesgut Military Hospital (2004–2005).

Assoc. Prof. Atakan Topçu, M.D., is a medical oncologist at Medipol University and Medipol Acıbadem Regional Hospital. He treats solid tumors, including lung, breast, colorectal, gastric, and neuroendocrine cancers. His work also covers targeted therapies, immunotherapy, geriatric oncology, and cancer-related malnutrition, cachexia, and sarcopenia.

He has authored more than 50 peer-reviewed papers. Recent work includes a 2024 Frontiers in Medicine study on geriatric syndromes and a 2023 Future Oncology paper on sarcopenia and anxiety in lung cancer. He has also published on the CONUT score in breast cancer and on malnutrition in HER2-negative metastatic gastric cancer.

Dr. Topçu serves on the Editorial Board of BMC Cancer. He is a member of the Turkish Society of Medical Oncology, ESMO, and the Turkish Geriatrics Society. Education and training: M.D., Uludağ University; residency in Internal Medicine, Marmara University; fellowship in Medical Oncology, Bezmialem Vakıf University.

Le Dr Salman possède une vaste expertise en oncologie acquise dans des institutions prestigieuses telles que le Memorial Sloan Kettering Cancer Center et le Moffitt Cancer Center.

• Plus de 15 ans de spécialisation en oncologie médicale
• Expert en thérapies ciblées et en immunothérapie
• Membre du conseil d'administration de la Société Turque d'Oncologie Médicale
• Actif dans la recherche clinique et les traitements expérimentaux
• Traiter des cas de cancer rares et complexes

Dr. Mariam Mohammed Hussein Abu Zeid is a clinical oncologist. She treats solid tumors and hematologic cancers. She earned her MBBCh from Ain Shams University in 2007 (Excellent). She completed a Master’s in Clinical Oncology and Nuclear Medicine in 2011 (Very Good). She received a Ph.D. in 2018 and an ESMO Certificate in 2015.

She leads and monitors clinical trials. Her work includes data collection and analysis. She administers chemotherapy and manages treatment toxicities. She also plans care with multidisciplinary teams. Her experience includes Ain Shams University Hospitals (2009–2012), the International Medical Center (2012–2014), and Wadi El Nile Hospital (2015–2019). Her roles covered diagnosis and staging, supportive care, quality improvement, and screening. She educates patients and families about the diagnosis, treatment options, and palliative care.

Professor Shixin Liu, MD, PhD, is the Discipline Leader of the Oncology Center. He is the former President of Jilin Provincial Cancer Hospital and former Director of the Cancer Prevention and Treatment Research Institute. He is a second-level professor and doctoral supervisor. He has received the State Council Special Government Allowance, the 4th National Famous Doctor (Outstanding Contribution) award, and the Model of Medical Ethics honor.

He specializes in the comprehensive diagnosis and treatment of malignant tumors. His focus is precision radiotherapy for thoracic and abdominal cancers. He is skilled in IMRT, VMAT, and SBRT for lung, esophageal, breast, and rectal cancers.

His leadership roles include Vice Chair of CMA Radiation Oncology, CACA Radiotherapy, and CACA Particle Therapy. He serves on the CSCO Standing Committee and as Vice Chair of the CSCO Radiation Oncology Expert Committee. He is Vice Chair of CPAM Radiation Oncology and a Standing Committee member of CSMEA. He chairs the Jilin Medical Association Radiation Oncology branch. He is on the editorial boards of the Chinese Journal of Radiation Oncology and the Practical Journal of Cancer.

Le Dr Inta Jaunalksne est spécialisée en virothérapie, l'un des domaines les plus récents de l'immunologie, avec plus de 30 ans d'expérience.

• Chef du centre d'immunologie clinique de l'hôpital universitaire clinique Pauls Stradins
• Diplômée de l'Institut médical de Riga avec un internat en médecine interne
• Se concentrer sur les traitements immunologiques innovants pour le cancer du cerveau

Dr. Muhammed Mustafa Atci is an Associate Professor of Medical Oncology at İstinye University, Liv Hospital Topkapı (2025–present). He previously served as Associate Professor and Education Coordinator at Prof. Dr. Cemil Taşcıoğlu City Hospital (2023–2025). He was also a Medical Oncologist there (2018–2021).

He has been a member of ASCO and the Turkish Society of Medical Oncology since 2018. He is the author or co-author of 19 peer-reviewed international papers on colon, breast, gastric, pancreatic, lung, thyroid, sarcoma, and colorectal cancers.

Notable works include a multicentre study on stage IIB colon cancer survival (Journal of Chemotherapy). He also studied the De Ritis ratio for lung metastasis in testicular cancer (Current Urology). His prognostic studies used PET/CT, MSI, lymph node ratio, and metabolic tumor volume.

Spécialisé dans le traitement des tumeurs cérébrales à l'Hôpital International Medicalpoint, avec une solide formation en oncologie de l'Université Hacettepe.

• Expérimenté dans le traitement de divers cancers, y compris les tumeurs cérébrales
• Formé à l'Université Hacettepe – un centre d'oncologie de premier plan
• Membre de l'ESMO et de l'Association Turque d'Oncologie Médicale

Pionnier de la recherche sur les syndromes neurologiques paranéoplasiques – Le Dr Graus en a défini les critères diagnostiques. Travaille à l'Hospital Quiron Barcelona.

• 39 ans d'expérience en neuro-oncologie
• Spécialisé dans les gliomes et les lymphomes cérébraux primitifs
• Ancien chef du service de neurologie de l'Hospital Clinic
• Fondateur et ancien président de l'EANO
• Doctorat honoris causa de l'Université de Lyon

Spécialisé dans la chirurgie endoscopique et l'ablation de tumeurs cérébrales au Samsung Medical Center – l'un des principaux hôpitaux de neurochirurgie en Corée du Sud.

• Traiter les patients pédiatriques et adultes
• Expertise dans les tumeurs cérébrales bénignes et malignes
• Maîtriser les techniques de radiochirurgie

Dr. Mohamed Mahmoud Abdelhakim is Head of Radiation Oncology at Shefa al Orman Hospital, Luxor. He is Professor of Radiation Oncology at the National Cancer Institute, Cairo University. He previously served as Associate Professor (2015–2020), Lecturer (2010–2015), Assistant Lecturer (2003–2009), and Resident (2000–2003). He also worked as a Specialist at Gharbia Cancer Society.

He treats inpatients and outpatients with breast, soft tissue sarcoma, lymphoma, gynecologic, gastrointestinal, genitourinary, and CNS tumors. His skills include image-guided brachytherapy, IMRT, VMAT, SRS, and SBRT. He performs conventional and CT-based planning and 3D-CRT. He works with cobalt and linear accelerators and electron beam therapy. He provides HDR and LDR intracavitary and interstitial brachytherapy. He also performs stereotactic radiotherapy, total body irradiation, and total skin irradiation.

Member: Egyptian Cancer Society, ESTRO, ESMO.

Dr. Maha Yahia is a medical oncologist and hemato-oncologist. She provides assessment, diagnosis, and treatment planning. Her treatments include chemotherapy, targeted therapy, and immunotherapy. She cares for patients with breast, genitourinary, gynecologic, thoracic, gastrointestinal, and rare cancers.

Education: M.B.B.Ch, Kasr El-Aini, Cairo University (1997–2003). Master in Hemato-oncology, National Cancer Institute, Cairo University (2008). Doctoral Degree in Hemato-oncology, National Cancer Institute, Cairo University (2015).

Experience: Resident in Medical Oncology, Maadi AFMC (2005–2010). Visitor Resident, NCI Cairo (2008–2009). Consultant Assistant, Prof. Hussein Khaled Clinic (2010–2017). Specialist, International Medical Center (2011–2012), Wadi El Nile Hospital (2013–2014), and Maadi AFMC (2011–2018). Head, Clinical Research Support Team, Maadi AFMC (2016–2018). Major (2014–2016) and Lt. Colonel Doctor (2016–2018), Egyptian Armed Forces. Lecturer of Clinical Research, AFCM (2019–2021).

Spécialisé en radiothérapie pour le cancer du cerveau, le Dr Michael Van Kampen propose des traitements ciblés à la Clinique Nordwest.

• Expertise ciblée en radiothérapie pour les tumeurs cérébrales
• Travailler à la Clinique Nordwest – un centre d'oncologie de premier plan
• Personnaliser les plans de traitement selon les besoins de chaque patient